Table 3.
Structure | System | Sign | Observed or reported (% of sample) | n = 25 unless stated otherwise |
---|---|---|---|---|
Cerebellum | Cerebellar ataxia (SARA ratings > 0) | Gait ataxia | 25 (100) | |
Stance ataxia | 21 (84) | |||
Dysarthria | 23 (92) | |||
Limb ataxia | 25 (100) | |||
Cerebellar oculomotor signs | Saccadic pursuit | 25 (100) | ||
Saccadic dysmetria | 24 (96) | |||
Gaze‐evoked nystagmus | 15 (60) | |||
Non‐ataxia movement disorder, observed or reported | Myoclonus | 10 (40) | ||
Dystonia | 8 (32) | |||
Tremor | 3 (12) | |||
Other symptoms or signs of suspected cerebellar attribution |
Diplopia | 11 (44) | ||
Dysphagia | 12 (48) | |||
Mild cognitive impairment by clinical suspicion or subjective complaint | 11 (44) | |||
Cognitive screening test positive | 6 (25) | (n = 24) | ||
Brainstem |
Brainstem oulomotor signs |
Ophthalmoparesis | 0 | |
Slowing of saccades | 0 | |||
Retina/optic nerve | Symptoms or signs of retinal/optic nerve involvement | Reduced visual acuity (monocular) | 0 | (n = 13) |
Optical coherence tomography pRNFL reduction | 0 | (n = 13) | ||
Spinal tract | Symptoms or signs of pyramidal involvement | Hyperreflexia | 5 (20) | |
Spasticity | 0 | |||
Plantar extensor | 0 | |||
Electrophysiology: CMCT abnormal | 0 | (n = 8) | ||
Symptoms or signs of spinal or peripheral involvement | Fasciculations | 5 (20) | ||
Muscle atrophy | 4 (16) | |||
Pareses | 3 (12) | |||
Reduced vibration sense (ankle) | 4 (16) | (n = 25) | ||
Electrophysiology: mild neuropathy | 8 (44) | (n = 18) | ||
Electrophysiology: SSEP abnormal | 5 (33) | (n = 15) | ||
Undefined | Symptoms of unclear attribution | Depression/anxiety screening test positive | 11 (48) | (n = 23) |
Depression/anxiety clinically relevant | 5 (22) | (n = 23) | ||
Cramps or sensation of muscle stiffness | 10 (40) | |||
Pain in legs or lower back unpexplained otherwise | 5 (20) |
CMCT, central motor conduction time; PRKCG, protein kinase C gamma; pRNFL, peripapillary retinal nerve fiber layer; SARA, scale for the assessment and rating of ataxia; SSEP, somatosensory‐evoked potentials; VUS, variant of uncertain significance.